How does erythromycin affect the metabolism of statins and what risks, such as increased statin toxicity, arise when these medications are co-administered?
Share
Sign Up to our social questions and Answers Engine to ask questions, answer people’s questions, and connect with other people.
Please briefly explain why you feel this question should be reported.
Please briefly explain why you feel this answer should be reported.
Please briefly explain why you feel this user should be reported.
Erythromycin inhibits CYP3A4 enzymes, increasing plasma levels of statins metabolized by this pathway, such as simvastatin, raising the risk of myopathy and rhabdomyolysis.